Page last updated: 2024-08-24

tirofiban and Vascular Diseases

tirofiban has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Z; Gong, W; Guan, S; Li, D; Li, Y; Liu, C; Xu, H; You, W1
Anderson, HV; Assali, AR; Fujise, K; Ghani, M; Moustapha, A; Rosales, OR; Salloum, J; Schroth, G; Sdringola, S; Smalling, RW1

Other Studies

2 other study(ies) available for tirofiban and Vascular Diseases

ArticleYear
Efficacy and safety of flow diverter combined with coil embolization and evidence-based antithrombotic regimen in the treatment of ruptured aneurysms.
    Neurosurgical focus, 2023, Volume: 54, Issue:5

    Topics: Aneurysm, Ruptured; Embolization, Therapeutic; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Retrospective Studies; Stents; Tirofiban; Treatment Outcome; Vascular Diseases

2023
Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003, Volume: 58, Issue:1

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Catheters, Indwelling; Cohort Studies; Dose-Response Relationship, Drug; Equipment Failure; Female; Femoral Artery; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Ischemia; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Retrospective Studies; Time Factors; Tirofiban; Tyrosine; Vascular Diseases

2003